Speaker illustration

Doctor Jakob Hytting

Vrinnevi Hospital, Norrkoping (Sweden)

* Cardiology resident * Certain interest in cardiac arrhythmias, particularly the management of atrial fibrillation (a-fib). * Currently doing my PhD focusing on a-fib management and biomarkers.

Unrecognized cardiovascular risks in young cervical cancer patients. Findings from the Rebuc study

Event: ESC Cardio-Oncology 2025

Topic: Diagnosis and Management of Cardiovascular Disease in Patients with Cancer

Session: Who is at risk of cardiovascular toxicity?

Thumbnail

Is thyroid function testing necessary in all cases of new onset atrial fibrillation diagnosed in the emergency department? - a real-life study

Event: EHRA 2024

Topic: Clinical

Session: Atrial fibrillation: clinical

Thumbnail